Literature DB >> 28315190

Posterior Superior Mesenteric Artery (SMA) First Approach vs. Standard Pancreaticoduodenectomy in Patients with Resectable Periampullary Cancers: a Prospective Comparison Focusing on Circumferential Resection Margins.

Sujoy Pal1, Joseph George2, Anand Narayan Singh2, Sandeep Mathur3, Nihar Ranjan Dash2, Pramod Garg4, Peush Sahni2, T K Chattopadhyay2.   

Abstract

BACKGROUND: The 'SMA-first' (P-SMA) pancreatoduodenectomy (PD) allows dissection directly on the right lateral aspect of superior mesenteric artery (SMA) which may decrease circumferential resection margin (CRM) positivity. This comparative study between standard PD (sPD) and P-SMA approach was planned focusing on CRM involvement.
METHODS: This was a prospective study comparing consecutive patients with resectable periampullary cancers (PACA) undergoing PD using the standard or P-SMA approach. The perioperative outcomes and the CRM positivity rates (specimens analysed according to the standardized Leeds pathology protocol (LEEPP)) were compared.
RESULTS: Overall, 39 patients (28 men; mean age 54 years; sPD 21, P-SMA 18) were included. Both groups were comparable with regard to demographic/tumour characteristics and perioperative outcomes. The P-SMA technique was significantly faster (321.1 ± 54.0 vs. 357.6 ± 55.8 min; p = 0.05). Though the mean tumour size (2.2 vs. 2.1 cm; p = 0.84) and T stage (T2 and T3) distribution were similar in both groups, lymph node yield was significantly higher in the P-SMA group (10.7 vs. 5.95; p = 0.001; mean 8 (2-21)). Though CRM positivity (margin <1 mm) occurred in 8 (21.1%), we did not find the P-SMA PD to yield significantly lower CRM positivity rates compared to the sPD (3/17 (17.6%) vs. 5/21(23.8%); p = 0.71). At a median follow-up of 28 months, fewer patients in the P-SMA PD group developed recurrence (2/15 vs. 5/19; p = 0.3) or died (3/15 vs. 7/19; p = 0.19), though this difference was not significant.
CONCLUSIONS: In patients with resectable PACA, P-SMA PD was significantly faster and yielded higher lymph node counts in the specimen but did not lower the rate of CRM positivity as determined by the LEEPP.

Entities:  

Keywords:  Circumferential resection margins; Pancreatoduodenectomy; SMA first

Mesh:

Year:  2018        PMID: 28315190     DOI: 10.1007/s12029-017-9933-x

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  25 in total

Review 1.  Resection margins and R1 rates in pancreatic cancer--are we there yet?

Authors:  C S Verbeke
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

2.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

3.  Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).

Authors:  Krishna V Menon; Dhanwant Gomez; Andrew M Smith; Alan Anthoney; Caroline S Verbeke
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

4.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

5.  Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach.

Authors:  Yosuke Inoue; Akio Saiura; Ryuji Yoshioka; Yoshihiro Ono; Michiro Takahashi; Junichi Arita; Yu Takahashi; Rintaro Koga
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

6.  R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.

Authors:  Bettina M Rau; Katharina Moritz; Sarah Schuschan; Guido Alsfasser; Friedrich Prall; Ernst Klar
Journal:  Surgery       Date:  2012-07-03       Impact factor: 3.982

7.  Effect of antecolic or retrocolic reconstruction of the gastro/duodenojejunostomy on delayed gastric emptying after pancreaticoduodenectomy: a randomized controlled trial.

Authors:  Rajesh Gangavatiker; Sujoy Pal; Amit Javed; Nihar Ranjan Dash; Peush Sahni; Tushar Kanti Chattopadhyay
Journal:  J Gastrointest Surg       Date:  2011-03-16       Impact factor: 3.452

8.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

9.  Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.

Authors:  Robert C G Martin; Charles R Scoggins; Vasili Egnatashvili; Charles A Staley; Kelly M McMasters; David A Kooby
Journal:  Arch Surg       Date:  2009-02

10.  Predictors of survival in periampullary cancers following pancreaticoduodenectomy.

Authors:  Ioannis Hatzaras; Nathaniel George; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2010-01-28       Impact factor: 5.344

View more
  2 in total

1.  Follow "the superior mesenteric artery": laparoscopic approach for total mesopancreas excision during pancreaticoduodenectomy.

Authors:  Edouardo Morales; Giuseppe Zimmitti; Claudio Codignola; Alberto Manzoni; Marco Garatti; Valentina Sega; Edoardo Rosso
Journal:  Surg Endosc       Date:  2019-07-22       Impact factor: 4.584

Review 2.  Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status.

Authors:  Anant Ramaswamy; Sujay Srinivas; Vikram Chaudhari; Prabhat Bhargava; Manish Bhandare; Shailesh V Shrikhande; Vikas Ostwal
Journal:  Ecancermedicalscience       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.